Vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor: implications for ocular angiogenesis.
about
PEDF and its roles in physiological and pathological conditions: implication in diabetic and hypoxia-induced angiogenic diseasesAlzheimer's disease and non-demented high pathology control nonagenarians: comparing and contrasting the biochemistry of cognitively successful agingPigment epithelium-derived factor protects retinal ganglion cells.Whole genome assessment of the retinal response to diabetes reveals a progressive neurovascular inflammatory responseEndogenous VEGF is required for visual function: evidence for a survival role on müller cells and photoreceptorsAqueous interleukin-6 levels are superior to vascular endothelial growth factor in predicting therapeutic response to bevacizumab in age-related macular degeneration.Role of vascular endothelial growth factor in the breakdown of the blood-aqueous barrier after retinal laser photocoagulation in pigmented rabbits.Characterisation of the vitreous proteome in proliferative diabetic retinopathy.Growth factors/chemokines in diabetic vitreous and aqueous alter the function of bone marrow-derived progenitor (CD34⁺) cells in humansPigment epithelium-derived factor inhibits retinal microvascular dysfunction induced by 12/15-lipoxygenase-derived eicosanoids.Endostar, a modified recombinant human endostatin, suppresses angiogenesis through inhibition of Wnt/β-catenin signaling pathwayExpression of pigment epithelium-derived factor and thrombospondin-1 regulate proliferation and migration of retinal pigment epithelial cells.Omega-3 supplementation combined with anti-vascular endothelial growth factor lowers vitreal levels of vascular endothelial growth factor in wet age-related macular degenerationPredictors of visual and anatomical outcomes for neovascular age-related macular degeneration treated with bevacizumab.Single periocular injection of celecoxib-PLGA microparticles inhibits diabetes-induced elevations in retinal PGE2, VEGF, and vascular leakage.Early onset vitreous amyloidosis in familial amyloidotic polyneuropathy with a transthyretin Glu54Gly mutation is associated with elevated vitreous VEGF.Proteome Profiling of Vitreoretinal Diseases by Cluster Analysis.Mechanical Stretching Promotes Skin Tissue Regeneration via Enhancing Mesenchymal Stem Cell Homing and Transdifferentiation.Beneficial Effects of Berberine on Oxidized LDL-Induced Cytotoxicity to Human Retinal Müller Cells.Thrombospondin-1 Deficiency Exacerbates the Pathogenesis of Diabetic Retinopathy.Delivery of celecoxib for treating diseases of the eye: influence of pigment and diabetesNegative regulators of angiogenesis: important targets for treatment of exudative AMD.Bevacizumab neutralizes the protective effect of vascular endothelial growth factor on retinal ganglion cellsInhibition of nuclear translocation of apoptosis-inducing factor is an essential mechanism of the neuroprotective activity of pigment epithelium-derived factor in a rat model of retinal degeneration.Pigment epithelium-derived factor receptor (PEDF-R): a plasma membrane-linked phospholipase with PEDF binding affinity.Osteopontin and other regulators of angiogenesis and fibrogenesis in the vitreous from patients with proliferative vitreoretinal disorders.PEDF expression affects retinal endothelial cell proangiogenic properties through alterations in cell adhesive mechanisms.Role of Inflammation in Diabetic Retinopathy.
P2860
Q27026916-82ED1167-833A-4CB8-A415-A623BEC22149Q28477836-4343810C-14F6-417C-B018-68E80425B41AQ33270756-B51751D4-1BF0-4412-AB47-C100AAEA1834Q33343728-9E6A87CD-197A-4239-B13C-B111153FD842Q33382103-0F68703F-09E8-489D-A875-1AEA058A5100Q33999935-248BEEEB-EDA6-48CA-BCC7-0349C556A3FDQ34051527-1AA721B0-F05E-4B81-A52C-8FEBD877BEBBQ34184946-409651FF-12D5-4439-BA60-E7D661F17DB6Q34355975-7A6A99DA-4198-41B3-87B9-ABDDB064978EQ35034418-212A9762-CC3F-4215-A29A-036EC97E3745Q35260978-8F7542ED-CA52-4B7F-8543-66CC64A56E04Q35294211-0821101C-E537-4F1E-85BF-D0B2E67A8CBFQ35316532-BB061CA3-31C6-4BC4-97D8-A14166A27D97Q35802709-043C3A0F-1A74-4504-9B84-02D455935693Q35885116-3DF44A25-9DA4-4B8F-906B-E4E7487760ECQ36830566-3F5C987F-ED88-487A-90D2-29B14CD13243Q37009808-EEC8612D-D543-43FB-A0CB-5287EB852FD9Q37042643-83E36885-9914-42A2-BBFA-4A8A38BAE247Q37126456-316CC451-CA4F-407B-90D6-BA1E435DBCC5Q37283355-FBD57666-1674-4A77-BEB2-2F714A911431Q37703235-501BA169-4FEB-4D8F-8275-4E84C082453CQ39416208-2A40AEDF-BA49-4958-BFE6-D4BD2009435DQ39638610-FE0C64F9-51D5-4C26-AEC6-28781B4D2A70Q39930640-5A30CFBE-6DEE-44B0-A407-5159A1C8955EQ41890533-06AA1BEA-FB1F-4582-92F8-294448D29759Q42469702-A8AA45FF-4BF7-449E-AF23-D98C46141405Q47876851-4866A221-0D06-418D-86AD-CF0F9A9F3536Q52642996-5DA747B9-F6FE-4ADD-9FA1-E2EA982091AF
P2860
Vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor: implications for ocular angiogenesis.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Vitreous levels of pigment epi ...... tions for ocular angiogenesis.
@en
Vitreous levels of pigment epi ...... tions for ocular angiogenesis.
@nl
type
label
Vitreous levels of pigment epi ...... tions for ocular angiogenesis.
@en
Vitreous levels of pigment epi ...... tions for ocular angiogenesis.
@nl
prefLabel
Vitreous levels of pigment epi ...... tions for ocular angiogenesis.
@en
Vitreous levels of pigment epi ...... tions for ocular angiogenesis.
@nl
P2093
P1476
Vitreous levels of pigment epi ...... ations for ocular angiogenesis
@en
P2093
Dante Pieramici
Elia J Duh
Eugene De Juan
Hoseong S Yang
J B Harlan
Julia A Haller
Mark S Humayun
Michele Melia
Peter A Campochiaro
Peter Gehlbach
P304
P356
10.1016/J.AJO.2003.11.015
P407
P50
P577
2004-04-01T00:00:00Z